Mette Kristensen1, Jane Kudsk, Susanne Bügel. 1. Dept. of Human Nutrition, Centre for Advanced Food Studies, University of Copenhagen, Rolighedsvej 30, 1958, Frederiksberg C, Denmark. mekr@life.ku.dk
Abstract
BACKGROUND: Cardiovascular disease is the major cause of death in the Western world, but some recent studies indicate that vitamin K may play a role in atherosclerosis protection. AIM OF STUDY: The aim of this study was to evaluate the effect of phylloquinone supplementation on blood lipids, inflammatory markers and fibrinolytic activity in postmenopausal women. METHODS:Thirty-one postmenopausal women completed this placebo-controlled, randomized crossover study and received 500 microg phylloquinone or placebo in addition to their habitual diet during two periods of 6 weeks' duration. Blood concentration of lipids, inflammatory markers and fibrinolytic parameters were measured after each period. RESULTS:Inflammatory markers, fibrinolytic parameters, total cholesterol and LDL-C were unaffected by the supplementation, whereas a 15% increase was seen in triacylglycerols (P = 0.015) and a 5% decrease in HDL-C (P = 0.06). CONCLUSIONS: Six weeks supplementation with a dose of phylloquinone similar to that obtainable from the diet induced a deterioration of the lipid profile with no improvement in any of the other risk markers analysed. Thus, these results do not support a cardioprotective effect of vitamin K as has been suggested by others.
RCT Entities:
BACKGROUND:Cardiovascular disease is the major cause of death in the Western world, but some recent studies indicate that vitamin K may play a role in atherosclerosis protection. AIM OF STUDY: The aim of this study was to evaluate the effect of phylloquinone supplementation on blood lipids, inflammatory markers and fibrinolytic activity in postmenopausal women. METHODS: Thirty-one postmenopausal women completed this placebo-controlled, randomized crossover study and received 500 microg phylloquinone or placebo in addition to their habitual diet during two periods of 6 weeks' duration. Blood concentration of lipids, inflammatory markers and fibrinolytic parameters were measured after each period. RESULTS: Inflammatory markers, fibrinolytic parameters, total cholesterol and LDL-C were unaffected by the supplementation, whereas a 15% increase was seen in triacylglycerols (P = 0.015) and a 5% decrease in HDL-C (P = 0.06). CONCLUSIONS: Six weeks supplementation with a dose of phylloquinone similar to that obtainable from the diet induced a deterioration of the lipid profile with no improvement in any of the other risk markers analysed. Thus, these results do not support a cardioprotective effect of vitamin K as has been suggested by others.
Authors: Todd C Villines; Christos Hatzigeorgiou; Irwin M Feuerstein; Patrick G O'Malley; Allen J Taylor Journal: Coron Artery Dis Date: 2005-05 Impact factor: 1.439
Authors: H Kawashima; Y Nakajima; Y Matubara; J Nakanowatari; T Fukuta; S Mizuno; S Takahashi; T Tajima; T Nakamura Journal: Jpn J Pharmacol Date: 1997-10
Authors: Susanne Bügel; A Dorthe Sørensen; Ole Hels; Mette Kristensen; Cees Vermeer; Jette Jakobsen; Albert Flynn; Christian Mølgaard; Kevin D Cashman Journal: Br J Nutr Date: 2007-02 Impact factor: 3.718
Authors: Johanna M Geleijnse; Cees Vermeer; Diederick E Grobbee; Leon J Schurgers; Marjo H J Knapen; Irene M van der Meer; Albert Hofman; Jacqueline C M Witteman Journal: J Nutr Date: 2004-11 Impact factor: 4.798
Authors: Sarah L Booth; Ligia Martini; James W Peterson; Edward Saltzman; Gerard E Dallal; Richard J Wood Journal: J Nutr Date: 2003-08 Impact factor: 4.798
Authors: M Kyla Shea; Sarah L Booth; Joseph M Massaro; Paul F Jacques; Ralph B D'Agostino; Bess Dawson-Hughes; José M Ordovas; Christopher J O'Donnell; Sekar Kathiresan; John F Keaney; Ramachandran S Vasan; Emelia J Benjamin Journal: Am J Epidemiol Date: 2007-11-15 Impact factor: 4.897
Authors: Joline W J Beulens; Daphne L van der A; Diederick E Grobbee; Ivonne Sluijs; Annemieke M W Spijkerman; Yvonne T van der Schouw Journal: Diabetes Care Date: 2010-04-27 Impact factor: 17.152